Characterization of AT2 receptor expression in NIH 3T3 fibroblasts
- PMID: 10081610
- PMCID: PMC11545429
- DOI: 10.1023/a:1006985329240
Characterization of AT2 receptor expression in NIH 3T3 fibroblasts
Abstract
1. A high expression of angiotensin II receptors and of angiotensin-converting enzyme (ACE) activity was detected in confluent NIH 3T3 fibroblasts. 2. Characterization with selective ligands, dithiothreitol, and GTP gamma S, indicated that only the AT2 subtype was expressed. 3. AT2 receptors and ACE expression were strictly dependent on the cell density and growth phase of the cells, with AT2 receptors being expressed earlier than ACE. In contrast, high expression of AT2 receptors irrespective of their growth state was observed in NIH 3T3 cells lacking contact inhibition upon neoplastic transformation with ras. 4. Our results imply a possible relation of AT2 receptors to cell growth and cell-cell contact.
Similar articles
-
Angiotensin II receptor subtypes and angiotensin-converting enzyme in the fetal rat brain.Brain Res. 1993 Dec 24;631(2):212-20. doi: 10.1016/0006-8993(93)91537-3. Brain Res. 1993. PMID: 8131049
-
Biochemical properties of the ovarian granulosa cell type 2-angiotensin II receptor.Endocrinology. 1991 Apr;128(4):1947-59. doi: 10.1210/endo-128-4-1947. Endocrinology. 1991. PMID: 1848506
-
Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.Regul Pept. 1997 Jan 29;68(2):111-7. doi: 10.1016/s0167-0115(96)02112-x. Regul Pept. 1997. PMID: 9110382
-
Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2 and AT4 receptors.J Hypertens. 1998 Dec;16(12 Pt 2):2027-37. doi: 10.1097/00004872-199816121-00026. J Hypertens. 1998. PMID: 9886893 Review.
-
Cross talk between angiotensin II type 1 and type 2 receptors: cellular mechanism of angiotensin type 2 receptor-mediated cell growth inhibition.Hypertens Res. 1999 Jul;22(2):67-74. doi: 10.1291/hypres.22.67. Hypertens Res. 1999. PMID: 10487321 Review.
Cited by
-
Angiotensin-converting enzyme inhibitor works as a scar formation inhibitor by down-regulating Smad and TGF-β-activated kinase 1 (TAK1) pathways in mice.Br J Pharmacol. 2018 Nov;175(22):4239-4252. doi: 10.1111/bph.14489. Epub 2018 Oct 8. Br J Pharmacol. 2018. PMID: 30153328 Free PMC article.
-
Telmisartan ameliorates glutamate-induced neurotoxicity: roles of AT(1) receptor blockade and PPARγ activation.Neuropharmacology. 2014 Apr;79:249-61. doi: 10.1016/j.neuropharm.2013.11.022. Epub 2013 Dec 4. Neuropharmacology. 2014. PMID: 24316465 Free PMC article.
-
Expression and transport of Angiotensin II AT1 receptors in spinal cord, dorsal root ganglia and sciatic nerve of the rat.Brain Res. 2008 Dec 30;1246:111-22. doi: 10.1016/j.brainres.2008.09.099. Epub 2008 Oct 17. Brain Res. 2008. PMID: 18976642 Free PMC article.
-
Pleiotropic Effects of Simvastatin and Losartan in Preclinical Models of Post-Traumatic Elbow Contracture.Front Bioeng Biotechnol. 2022 Feb 21;10:803403. doi: 10.3389/fbioe.2022.803403. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35265595 Free PMC article.
-
Angiotensin-converting enzyme inhibitor reduces scar formation by inhibiting both canonical and noncanonical TGF-β1 pathways.Sci Rep. 2018 Feb 20;8(1):3332. doi: 10.1038/s41598-018-21600-w. Sci Rep. 2018. PMID: 29463869 Free PMC article.
References
-
- Bottari, S. P., de Gasparo, M., Steckelings, U. M., and Levens, N. R. (1993). Angiotensin II receptor subtypes: Characterization, signalling mechanisms, and possible physiological implications. Frontiers Neuroendocrinol. 14:123–171. - PubMed
-
- Bumpus, F. M., Catt, K. J., Chiu, A. T., de Gasparo, M., Goodfriend, T., Husain, A., Peach, M. J., Taylor, D. G., Jr., and Timmermans, P. B. M. W. M. (1991). Nomenclature for angiotensin receptors: A report of the nomenclature committee of the council for high blood pressure research. Hypertension17:720–723. - PubMed
-
- Chiu, A. T., Duncia, J. V., McCall, D. E., Wong, P. C., Price, W. A., Thoolen, M. J. M. C., Carini, D. J., Johnson, A. L., and Timmermans, P. B. M. W. M. (1989a). Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies. J. Pharmacol. Exp. Ther.250:867–874. - PubMed
-
- Chiu, A. T., Herblin, W. F., McCall, D. E., Ardecky, R. J., Carini, D. J., Duncia, J. V., Pease, L. J., Wong, P. C., Wexler, R. R., Johnson, A. L., and Timmermans, P. B. M. W. M. (1989b). Identification of angiotensin II receptor subtypes. Biochem. Biophys. Res. Commun.165:196–203. - PubMed
-
- de Gasparo, M., Husain, A., Alexander, W., Catt, K. J., Chiu, A. T., Drew, M., Goodfriend, T., Harding, J. W., Inagami, T., and Timmermans, P. B. M. W. M. (1995). Proposed update of angiotensin receptor nomenclature. Hypertension25:924–927. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous